What is the recommended dose of Ascoril D (Bronchodilator syrup)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Ascoril D (Bronchodilator Syrup)

The standard recommended dose of Ascoril D expectorant is 10 ml taken three times daily for adults and appropriate weight-based dosing for children above 3 years of age.

Dosage Guidelines

Adult Dosing

  • Standard adult dose: 10 ml three times daily 1
  • Duration of treatment typically ranges from 7-15 days depending on symptom resolution 2
  • Most patients report good therapeutic effect within 1 day after starting treatment 1

Pediatric Dosing

  • For children above 3 years: Weight-based dosing is recommended 1
  • Ascoril D is not recommended for children under 3 years of age 1
  • Pediatric dosing should be adjusted according to body weight and severity of symptoms 2

Clinical Efficacy

  • Studies have shown that Ascoril expectorant is effective for treating cough in both children (>3 years) and adults up to 78 years with acute respiratory infections and bronchitis 1
  • Comparative studies demonstrate that Ascoril provides quicker and better symptom relief compared to other cough formulations 2
  • In clinical trials, 96% of physicians rated Ascoril as having "high" or "very high" effectiveness for cough management 2

Composition and Mechanism

  • Ascoril D contains multiple active ingredients that work synergistically:
    • Salbutamol/Levosalbutamol: Bronchodilator component that relieves bronchospasm 3
    • Guaifenesin: Expectorant that helps loosen mucus 2
    • Bromhexine: Mucolytic agent that breaks down mucus 4

Safety Considerations

  • Well-tolerated with minimal adverse effects reported in clinical studies 1
  • Monitoring for common beta-agonist side effects (tremor, tachycardia) is recommended, especially in patients with cardiovascular conditions 3
  • Should be used with caution in patients with diabetes, hypertension, or thyroid disorders due to the sympathomimetic effects of salbutamol 3

Duration of Treatment

  • Treatment duration typically ranges from 7-15 days 2
  • Continuation beyond 2 weeks should be based on reassessment of symptoms 1, 2
  • Most patients show significant improvement within the first few days of treatment 1

Common Pitfalls and Caveats

  • Avoid concurrent use with other beta-agonist medications to prevent additive effects 3
  • Not recommended for dry, non-productive cough as it contains expectorant and mucolytic components 2
  • Should not be used in children under 3 years of age 1
  • Patients with known hypersensitivity to any of the components should avoid using this medication 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.